Optimizing Display,Analysis,Interpretation and Utility of Self-Monitoring of Blood Glucose (SMBG) Data for Management of Patients with Diabetes

Abstract

Background:

Self-monitoring of blood glucose (SMBG) data have not been used to fullest advantage. Few physicians routinely download data from memory-equipped glucose meters and perform systematic analyses and interpretation of the data. There is need for improved methods for display and analysis of SMBG data, for a systematic approach for identification and prioritization of clinical problems revealed by SMBG, for characterization of blood glucose variability, and for clinical decision support.

Methods:

We have developed a systematic approach to the analysis and interpretation of SMBG data to assist in the management of patients with diabetes. This approach utilizes the following criteria: 1) Overall quality of glycemic control; 2) Hypoglycemia (frequency, severity, timing); 3) Hyperglycemia; 4) Variability; 5) Pattern analysis; and 6) Adequacy of monitoring. The “Pattern analysis” includes assessment of: Trends by date and by time of day; relationship of blood glucose to meals; post-prandial excursions; the effects of day of the week, and interactions between time of day and day of the week.

Results:

The asymmetrical distribution of blood glucose values makes it difficult to interpret the mean and standard deviation. Use of the median (50^th percentile) and Inter-Quartile Range (IQR) overcomes these difficulties: IQR is the difference between the 75^th and 25^th percentiles. SMBG data can be used to predict the A1c level and indices of the risks of hyperglycemia and hypoglycemia.

Conclusion:

Given reliable measures of glucose variability, one can apply a strategy to progressively reduce glucose variability and then increase the intensity of therapy so as to reduce median blood glucose and hence A1c, while minimizing the risk of hypoglycemia.

Keywords

clinical decision support diabetes glucose medical informatics self-monitoring statistics variability

References

Karter

Parker

Moffet

Spence

Chan

Ettner

Selby

. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006; 29 (8): 1757–63.

Blonde

Karter

. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med. 2005 Sep; 118 (Suppl 9A): 20S–26S.

Karter

Ackerson

Darbinian

D'Agostino

Ferrara

Liu

Selby

. Self Monitoring of Blood Glucose Levels and Glycemic Control: The Northern California Kaiser Permanente Diabetes Registry. Am. J. Med 2001; 111: 1–9.

Pernick

Rodbard

Personal computer programs to assist with self-monitoring of blood glucose and self-adjustment of insulin dosage. Diabetes Care. 1986; 9 (1): 61–9.

Mazze

Lucido

Langer

Hartmann

Rodbard

Ambulatory glucose profile: Representation of verified self-monitored blood glucose data. Diabetes Care. 1987 Jan-Feb; 10 (1): 111–7.

Rodbard

Potential role of computers in clinical investigation and management of diabetes mellitus. Diabetes Care. 1988 Nov-Dec; 11 Suppl 1: 54–61.

Berger

Rodbard

Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care. 1989 Nov-Dec; 12 (10): 725–36. Berger

Rodbard

. Comput Methods Programs Biomed. 1991; 34 (4): 241–53. A pharmacodynamic approach to optimizing insulin therapy.

Shultz

Bauman

Hayward

Rodbard

Holzman

Improved diabetic prognosis following telecommunication and graphical processing of diabetic data. Proc Annu Symp Comput Appl Med Care. 1991: 53–7.

Berger

Gelfand

Miller

, Combining statistical, rule-based, and physiologic model-based methods to assist in the management of diabetes mellitus. Comput Biomed Res. 1990 Aug; 23 (4): 346–57.

10.

Rodbard

Berger

Pernick

Computer, networking, and information systems to facilitate delivery of health care to patients with diabetes. In: Baba

Kaneko

(Eds.), Diabetes 1994, Proceedings of the 15th International Diabetes Federation Congress, Kobe, 6 — 11 November 1994. Elsevier, Amsterdam, pp. 800–803, 1995.

11.

Rodbard

Vigersky

(2004) Development of Algorithms for Clinical Decision Support for Primary Care Providers, Annual Meeting, Philadelphia, PA, October 28, 2004. Diabetes Technology and Therapeutics, March, 2005; 7 (2): 409.

12.

Hirsch

, Glycemic variability: It's not just about A1c anymore! Diabetes Technol Ther. 2005 Oct; 7 (5): 780–3.

13.

Hirsch

Brownlee

. Should minimal blood glucose variability become the gold standard of glycemic control? Diabetes Complications 2005 19 (3): 178–181.

14.

Brownlee

Hirsch

, Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006 Apr 12; 295 (14): 1707–8.

15.

Monnier

Mas

Ginet

Michel

Villon

Cristol

Colette

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. JAMA. 2006 Apr 12; 295 (14): 1681–7.

16.

Ceriello

Hanefeld

Leiter

Monnier

Moses

Owens

Tajima

, Tuomilehto, J, for the International Prandial Glucose Regulation (PGR) Study Group. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004; 164: 2090–2095.

17.

Esposito

Giugliano

Nappo

Marfella

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in Type 2 diabetes mellitus. Circulation 2004; 110: 214–219.

18.

Yemelkova-Jurtschiev

Kohler

Henkel

Leonhardt

Fuecker

Hanefeld

: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830–1834.

19.

Meigs

Nathan

D'Agostino

Wilson

. Fasting and post-challenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 2002; 25: 1845–1850.

20.

Kilpatrick

Rigby

Atkin

, The effect of glucose variability on the risk of microvascular complications in Type 1 diabetes. Diabetes Care. 2006; 29 (7): 1486–90.

21.

Hsu

Laffel

Meneghina

McGill

. An Electronic Logbook Maintains Improvement in Glycemic Control: Observational Assessment Following a Randomized Controlled Trial. Diabetes 55 (Suppl. 2); 2006:. A93. Poster 396-P.

22.

Kovatchev

Cox

Gonder-Frederick

Clarke

. Methods for quantifying and monitoring home glucose profiles exemplified by an examination of blood glucose patterns in patients with Type 1 and Type 2 diabetes. Diabetes Technol Ther 2002; 4: 295–303.

23.

Kovatchev

Clarke

Breton

Brayman

McCall

Quantifying Temporal Glucose Variability in Diabetes via Continuous Glucose Monitoring: Mathematical Models and Clinical Application. Diabetes Technol Ther 2005; 7 (6): 849–862.

24.

Kovatchev

Cox

, Numerical estimation of HbA(1c) from routine self-monitoring data in people with Type 1 and Type 2 diabetes mellitus. Methods Enzymol. 2004; 384: 94–106.

25.

Otto

Sharma

Bhensdadia

Kovatchev

Muralidharan . Relationship of Measures of Glucose Variability with Out of Control Glucose Results. Diabetes 55 (Suppl. 2); 2006:. A95. Abstract 405-P.

26.

Schlichtkrull

Munck

Jersild

(1965). The M-value, an index of blood-sugar control in diabetics. Acta Med Scand., 177, 95–102.

27.

Service

F.J.

O'Brien

P.C.

Rizza

R.A.

(1987). Measurements of glucose control. Diabetes Care, 10, 225–237.

28.

Skyler

J.S.

Alberti

G.M

. (1980). Clinical assessment of metabolic control in insulin dependent diabetes mellitus. Diabetes Care, 3, 369–370.

29.

Wojcicki

(1995). “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res., 27, 41–42.

30.

Rodbard

(2005) Improved Methods for Calculating a “Figure of Merit” for Blood Glucose Monitoring Data. Diabetes Technology Meeting, San Francisco CA, November 2005.

31.

Nathan

Turgeon

Regan

Translation of Glycosylated Hemoglobin Levels into Mean Blood Glucose (MBG) Levels, Revisited. Abstract 408.5- P. Diabetes 2006; 55 (Suppl. 2): A96.

32.

Saudek

Derr

Kalyani

, Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006; 295: 1688–1697.

33.

Kennedy

Herman

W.H.

Strange

, Harris, A, for the GOAL A1c TEAM. Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients with Type 2 Diabetes. Diabetes Care 2006; 29: 1–8.

34.

Raskin

Allen

Hollander

Lewin

Gabbay

R.A.

Bode

Garber

., FOR THE INITIATE STUDY GROUP. Diabetes Care 2005; 28: 260–265.

35.

Yki-Järvinen

Kauppinen-Mäkelin

Tiikkainen

Vähätalo

Virtano

Nikkilä

Tulokas

Hulme

Hardy

McNulty

Hänninen

Levänen

Lahdenperä

Lehtonen

Ryysy

Insulin Glargine or NPH combined with Metformin in Type 2 diabetes: The LANMET study. Diabetologia 2006; 49: 442–451.

36.

Tukey

J.W.

(1977). Exploratory data analysis. Reading, MA: Addison-Wesley Publishing Company.